Please note that the URL for this site has changed to a '' address from ''. This reflects changes we have made to hosting for this site.

The UK NSC recommendation on Thrombophilia screening in pregnancy, newborns and adults (currently under review)


This recommendation is currently being reviewed as part of the UK NSC's regular review cycle of all policies.

The review process began in Aug 2016 and is estimated to be completed by Jul 2017.

Recommendation Systematic population screening programme not recommended
Key downloads

The above zip file contains two review documents -one for antenatal screening for thrombophilia, and the other for neonatal and general adult population screening for thrombophilia.


Find general information about population health screening.

More about Thrombophilia

Thrombophilia is a condition where the blood has an increased tendency to form clots. This clotting is called thrombosis. There are many different causes, some of which are hereditary. Some people with thrombophilia have no problems, whereas others may need to take medication to prevent or treat clots.

» Read more about thrombosis and thrombophilia on NHS Choices


• Dr Roopen Arya
Royal College of Obstetricians and Gynaecologists
Royal College of Pathologists
Royal College of Physicians
Royal College of Physicians and Surgeons of Glasgow
Royal College of Physicians of Edinburgh

The stakeholder groups will be involved when the recommendation is next reviewed. If you think your organisation should be added, please contact us. More information for stakeholders can be found in appendix C of the UK NSC evidence review process.

Recommendation Review History

The previous review of screening for thrombophilia (2010) covered screening in pregnancy, in newborns and in adults. The current review divides screening into two populations; antenatal, and neonatal and general adult population.

Related documents

icon Thrombophilia screening review 2010 (PDF document, 79KB, 07/02/17)

More options

Go to top